Researcher.Life Logo

International Clinical Psychopharmacology : Impact Factor & More

eISSN: 1473-5857pISSN: 0268-1315

Key Metrics

CiteScore
3.7
H-Index
95
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
0.73
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on International Clinical Psychopharmacology

International Clinical Psychopharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1986
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in International Clinical Psychopharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in International Clinical Psychopharmacology

Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.
  • 13 May 2026
  • International clinical psychopharmacology
Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD).
  • 1 May 2026
  • International clinical psychopharmacology
Unspoken needs: an essential perspective in the treatment of schizophrenia.
  • 1 May 2026
  • International clinical psychopharmacology
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).
  • 29 Apr 2026
  • International clinical psychopharmacology
Aripiprazole‑induced akathisia associated with bilateral putaminal hypermetabolism on PET.
  • 14 Apr 2026
  • International clinical psychopharmacology
Drug development in autism spectrum disorder: genetic heterogeneity, failed trials, and the case for stratified pharmacotherapy.
  • 10 Apr 2026
  • International clinical psychopharmacology
Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.
  • 13 May 2026
  • International clinical psychopharmacology
Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD).
  • 1 May 2026
  • International clinical psychopharmacology
Unspoken needs: an essential perspective in the treatment of schizophrenia.
  • 1 May 2026
  • International clinical psychopharmacology
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).
  • 29 Apr 2026
  • International clinical psychopharmacology
Aripiprazole‑induced akathisia associated with bilateral putaminal hypermetabolism on PET.
  • 14 Apr 2026
  • International clinical psychopharmacology
Drug development in autism spectrum disorder: genetic heterogeneity, failed trials, and the case for stratified pharmacotherapy.
  • 10 Apr 2026
  • International clinical psychopharmacology

FAQs on International Clinical Psychopharmacology